Navigation Links
Common Chemical From Seaweed Could Help In The Fight Against Cervical Cancer Virus-HPV

Researchers claim that a common chemical used to thicken everything from baby food to sexual lubricants may help fight the virus that causes cervical cancer// and genital warts.

Researchers found the thickener, carrageenan, prevented human papilloma viruses (HPV) from attaching to cells in laboratory tests. Certain strains of HPV can cause cervical cancer and genital warts.

In the study conducted by researchers from the National Cancer Institute, who reported their findings in Pathogens, a journal published by the Public Library of Science (PloS), it was reported that carrageenan, which is derived from red algae, may be developed and used to prevent HPV infection at low cost. However adding that their studies are yet to be confirmed, the researchers found that in a test tube, carrageenan inhibits the infectious ability of genital HPV with nearly a thousand-fold greater potency than other inhibitors tested.

It was reported that the FDA had recently approved a vaccine that targets HPV for the prevention of cervical cancer in women who might be at risk. But researchers also said that it doesn't protect against every strain of HPV and with its costs of around $360, it could prove to be too expensive for use in developing countries.

Explaining that the carrageenan, which is derived from the seaweed, red algae, could probably turn out to be best suited for testing as the thickener as its commonly used commercially is already used in sexual lubricants and other topically applied products, and food stuffs. They explained that HPV normally acts by attacking the cells by attaching themselves to the proteins present on the cell surfaces and then chemically gaining access to the cells. They further explained that the carrageenan prevented infection by stopping the virus from attaching to the cells.

John Schiller, senior investigator at the National Cancer Institute, in a press release said, "We were floored by how muc h better it worked than anything else we have tested. It's effective at 100-fold lower concentration than the next best inhibitor we've found. Further cautioning he added, "Our results do not prove that carrageenans will work as a practical HPV topical microbicide. The potent inhibition of infection of cells in dishes, coupled with the fact that carrageenan-based products are already in use for genital application, are promising, but we will need to do a well-controlled clinical trial before use of any of these products as an HPV inhibitor could be recommended."

Dr. Connie Trimble, an HPV researcher at Johns Hopkins University, explaining that this type of cancer require multiple weapons for treatment described the discovery as "a great thing." Trimble has been involved in the early preventive vaccine trials and is currently working on a maintenance vaccine for women who already have HPV.


'"/>




Related medicine news :

1. Common contraception
2. Common Cold Remedy May Treat SARS
3. Common Plant Triggers Asthma
4. Pain Common in People with MS
5. Common Cold Found to Fight Cancer
6. Bullying – a Common Problem Among Childre
7. Common Medication Errors in Children
8. A Common Cause Of Allergy That Goes Unnoticed
9. Genetic Breakthrough in Common Eye Problem
10. Common Cold Found to Fight Cancer Cells
11. Side Effects Of Some Common Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: